European Journal of Chemistry

Investigate the level of IL-8 in patients with diabetes mellitus and its relation with lipid profile and the incidence of atherosclerosis



Main Article Content

Ammal Esmaeel Ibrahim

Abstract

IL-8 is a member of the CXC class of chemokines and is chemotactic for neutrophils. The cellular activation of IL-8 takes place after IL-8 binding to its receptor in the presence of calcium and protein kinase, leading to neutrophil activation and chemo taxis in infection and inflammation. Therefore, IL-8 tasks to mediate neutrophil recruitment, accumulation, and activation. The study included 50 patients with diabetes mellitus divided into a female group, which contained 16 female patients with an age range of 39-69 years, and a male group which contained 34 male patients with an age range of 40-72 years. Control groups contained forty healthy individuals divided into a female group, which contained 16 healthy females with an age range of 35-68 years, and a male group which contained 24 males with an age range of 39-69 years. ELISA kits were used to measure insulin and IL-8. The levels of insulin and IL-8 were considerably elevated throughout (p < 0.001), total cholesterol, Low Density Lipoprotein (LDL), were significantly elevated (p < 0.001) in all patients as well. There was positive correlation between Interleukin-8 with LDL, while there was negative correlation with total cholesterol and High Density Lipoprotein (HDL). Interleukin-8 levels increase with obesity in patients and control groups, Interleukin-8 positively correlated with LDL-cholesterol and negatively correlated with HDL-C thus make us consider it as atherogenic factor, the increase in the level of IL-8 in patients who have diabetes mellitus may indicate increasing the incidence of atherosclerosis.


icon graph This Abstract was viewed 6023 times | icon graph Article PDF downloaded 690 times

How to Cite
(1)
Ibrahim, A. E. Investigate the Level of IL-8 in Patients With Diabetes Mellitus and Its Relation With Lipid Profile and the Incidence of Atherosclerosis. Eur. J. Chem. 2014, 5, 529-531.

Article Details

Share
Crossref - Scopus - Google - European PMC
References

[1]. Suseela, S.; Michael, Y.; Eric, C.; Melissa, E.; Hatley, A. E. Circ. Res. 2003, 92, 371-377.
http://dx.doi.org/10.1161/01.RES.0000061714.74668.5C

[2]. Gross, M. D.; Shapiro, B.; Fig, L. M.; Steventon, R.; Skinner, R. W. S.; Hay, R. V. J. Nucl. Med. 2001, 42(11), 1656-1659.

[3]. American Society of Health-System Pharmacists (2009-02-01). Insulin Injection. PubMed Health. National Center for Biotechnology Information, U. S. National Library of Medicine. Retrieved 2012-10-12.

[4]. Rao, U. M.; Sreenivasulu, M.; Chengaiah, B.; Reddy, K. C.; Chetty, C. M. Int. J. PharmTech. Res. 2010, 2(3), 1883-1892.

[5]. Mohamed-Ali, V.; Goodrick, S.; Rawesh, A.; Katz, D. R.; Miles, J. M.; Yudkin, J. S. J. Clin. Endocr. Metab. 1997, 82, 4196-4200.

[6]. Hotamisligil, G. S.; Spiegelman, B. M. Diabetes 1994, 43, 1271-1278.
http://dx.doi.org/10.2337/diab.43.11.1271

[7]. Bruun, J. M.; Pedersen, S. B.; Richelsen, B. J. Clin. Endocr. Metab. 2001, 86, 1267-1273.

[8]. Gerhardt, C. C.; Romero, I. A.; Cancello, R.; Camoin, L.; Strosberg, A. D. Mol. Cell. Endocrinol. 2001, 175, 81-92.
http://dx.doi.org/10.1016/S0303-7207(01)00394-X

[9]. Shin, W. S.; Szuba, A.; Rockson, S. G. Atherosclerosis 2002, 160, 91-102.
http://dx.doi.org/10.1016/S0021-9150(01)00571-8

[10]. Kopelman, P. G. Nature 2000, 404, 635-643.

[11]. Bruun, J. M.; Pedersen, S. B.; Kristensen, K.; Richelsen, B. Obes. Res. 2002, 10, 499-506.
http://dx.doi.org/10.1038/oby.2002.68

[12]. Gerszten, R. E.; Garcia-Zepeda, E. A.; Lim, Y. C.; Yoshida, M.; Ding, H. A.; Gimbrone, M. A. Jr.; Luster, A. D.; Luscinskas, F. W.; Rosenzweig, A. Nature 1999, 398, 718-723.
http://dx.doi.org/10.1038/19546

[13]. Huo, Y.; Weber, C.; Forlow, S. B.; Sperandio, M.; Thatte, J.; Mack, M.; Jung, S.; Littman, D. R.; Ley, K. J. Clin. Invest. 2001, 108, 1307-1314.
http://dx.doi.org/10.1172/JCI12877

[14]. Yeh, M.; Leitinger, N.; Martin, R.; Onai, N.; Matsushima, K.; Vora, D. K.; Berliner, J. A.; Reddy, S. T. Arterioscler. Thromb. Vasc. Biol. 2001, 21, 1585-1591.
http://dx.doi.org/10.1161/hq1001.097027

[15]. Sushil, K.; Justin, L.; Jennifer, L. Antioxid. Redox Sign. 2007, 9(10), 1581-1590.
http://dx.doi.org/10.1089/ars.2007.1577

[16]. Richelse, J. M.; Bruun, C. V.; Soren, T.; Arne, A. Eur. J. Endocrinol. 2003, 148, 535-542.
http://dx.doi.org/10.1530/eje.0.1480535

Supporting Agencies

Most read articles by the same author(s)
TrendMD

Dimensions - Altmetric - scite_ - PlumX

Downloads and views

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...
License Terms

License Terms

by-nc

Copyright © 2024 by Authors. This work is published and licensed by Atlanta Publishing House LLC, Atlanta, GA, USA. The full terms of this license are available at https://www.eurjchem.com/index.php/eurjchem/terms and incorporate the Creative Commons Attribution-Non Commercial (CC BY NC) (International, v4.0) License (http://creativecommons.org/licenses/by-nc/4.0). By accessing the work, you hereby accept the Terms. This is an open access article distributed under the terms and conditions of the CC BY NC License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited without any further permission from Atlanta Publishing House LLC (European Journal of Chemistry). No use, distribution, or reproduction is permitted which does not comply with these terms. Permissions for commercial use of this work beyond the scope of the License (https://www.eurjchem.com/index.php/eurjchem/terms) are administered by Atlanta Publishing House LLC (European Journal of Chemistry).